Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alimera Sciences Inc (NASDAQ:ALIM)

1.15
Delayed Data
As of Jan 23
 -0.03 / -2.54%
Today’s Change
1.01
Today|||52-Week Range
5.15
+6.48%
Year-to-Date
No recent news for Alimera Sciences Inc.

Today’s Trading

Previous close1.18
Today’s open1.16
Day’s range1.14 - 1.17
Volume234,826
Average volume (3 months)278,019
Market cap$76.5M
Dividend yield--
Data as of 01/23/2017

Growth & Valuation

Earnings growth (last year)+24.18%
Earnings growth (this year)+42.52%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+166.39%
P/E ratioNM
Price/Sales4.79
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CEMIChembio Diagnostics ...0.000.00%
IPCIIntellipharmaceutics...+0.02+0.79%
SCYXSCYNEXIS Inc-0.12-3.66%
PPHMPeregrine Pharmaceut...+0.00+1.43%
Data as of 01/23/2017

Financials

Next reporting dateMarch 8, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$22.4M
Annual profit (last year)-$30.6M
Net profit margin-136.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Charles Daniel Myers
President &
Chief Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts


Search for Jobs